The experiments, thus far performed only in mice, appear to overcome a major drawback of vaccinations - the lag time of days, or even weeks, that it normally takes for immunity to build against a pathogen. This new method ...
Mar 02, 2009
4.6 / 5 (19)
0
Researchers at the University of Illinois at Chicago College of Medicine have developed a transgenic mouse that carries a human gene known to increase risk of Alzheimer's 15-fold. This new mouse mimics the ...
Nov 08, 2012
5 / 5 (2)
0
|
(Phys.org)—Smart viruses find ways around host defenses. In the case of the influenza viruses A and B, rapid genetic changes and resistance to available therapies make it hard to combat flu epidemics in ...
Oct 11, 2012
4.5 / 5 (2)
0
|
Computer-designed proteins are under construction to fight the flu. Researchers are demonstrating that proteins found in nature, but that do not normally bind the flu, can be engineered to act as broad-spectrum ...
Jun 01, 2012
5 / 5 (7)
0
|
A mixture of current drugs and carbon nanoparticles shows potential to enhance treatment for head-and-neck cancers, especially when combined with radiation therapy, according to new research by Rice University ...
Feb 16, 2012
5 / 5 (3)
0
|
The next big thing in medical diagnostics could be minutes particles of rust, iron oxide, coated with the material from which sand is formed, silicon dioxide. These magnetic nanoparticles, a mere 29 to 230 nanometers across, ...
Jan 31, 2011
5 / 5 (2)
0
|
Glioblastoma, the most common and lethal form of brain cancer and the disease that killed Massachusetts Senator Ted Kennedy, resists nearly all treatment efforts, even when attacked simultaneously on several ...
Jan 24, 2011
5 / 5 (7)
1
|
Using a two-step process that creates gold nanoparticles that look like kernels of popcorn, researchers at Jackson State University have created a targeted nanoparticle that can detect as few as 50 malignant prostate cells ...
Jan 19, 2011
3.5 / 5 (2)
0
|
A monoclonal antibody targeting a well known cell surface protein inhibited prostate cancer growth and metastasis in an aggressive form of the disease that did not respond to hormone therapy, according to a study by researchers ...
Nov 08, 2010
5 / 5 (2)
0
|
One of the most promising characteristics of nanoparticles as diagnostic agents is the ability to attach to the nanoparticles surface any of a wide variety of targeting molecules that can increase the distinction between ...
Sep 17, 2010
5 / 5 (2)
0
|
(PhysOrg.com) -- Using nanoporous silicon particles, two teams of investigators have created drug delivery vehicles capable of ferrying labile molecular therapies deep into the body. Both groups believe their new drug delivery ...
May 26, 2010
5 / 5 (1)
0
|
(PhysOrg.com) -- One important discovery made about cancer over the past decade is that as a tumor develops, the molecular identity of its cells begins to diverge. As a result, any given tumor is likely to contain groups ...
May 25, 2010
5 / 5 (2)
0
|
Pharmaceutical companies could substantially reduce the expense of costly treatments for cancer and other diseases produced from mammalian or bacterial cells by growing these human therapeutic proteins in ...
Mar 08, 2010
4 / 5 (2)
1
|
The first head-to-head comparison of therapeutic monoclonal antibodies produced from plants versus the same antibodies produced from mammalian cells has shown that plant-produced antibodies can fight infection equally well.
Feb 08, 2010
4.7 / 5 (3)
0
|
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, ...
Nov 22, 2009
5 / 5 (1)
0
